Skip to main content
Top
Published in: Clinical Rheumatology 11/2013

01-11-2013 | Letter to Editor

Gout: from international guidelines to current practice. Results from a physician questionnaire

Authors: Tristan Pascart, René-Marc Flipo

Published in: Clinical Rheumatology | Issue 11/2013

Login to get access

Excerpt

Li et al. recently addressed in this journal the issue of the knowledge of gout by patients and physicians in China, showing a rather poor awareness of its management by non-rheumatologists [1]. Similar data was also recently gathered in the USA by Harrold et al. [2]. The overall conclusion was a profound inconsistency between physicians’ habits and international guidelines, thus suggesting very common care deficiencies in gout. However, this survey was prior to the 2012 American College of Rheumatology (ACR) guidelines [3, 4] which may have contributed to such inconsistency. Roddy et al. [5] had previously provided data giving similar results of the lack of concordance between gout management in the UK and at the time, the very recent European League against Rheumatism (EULAR) recommendations [6, 7]. …
Literature
1.
go back to reference Li QH, Dai L, Li ZX, Liu HJ, Zou CJ, Ou-Yang X, Lu M, Li T, Li YH, Mo YQ, Schumacher HR (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. In press Li QH, Dai L, Li ZX, Liu HJ, Zou CJ, Ou-Yang X, Lu M, Li T, Li YH, Mo YQ, Schumacher HR (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. In press
2.
go back to reference Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA (2013) Primary care providers’ knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford) 52:1623–1629CrossRef Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA (2013) Primary care providers’ knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford) 52:1623–1629CrossRef
3.
go back to reference Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1431–1446CrossRef Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1431–1446CrossRef
4.
go back to reference Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64:1447–1461CrossRef Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64:1447–1461CrossRef
5.
go back to reference Roddy E, Zhang W, Doherty M (2007) Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 66:1311–1315PubMedCrossRef Roddy E, Zhang W, Doherty M (2007) Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 66:1311–1315PubMedCrossRef
6.
go back to reference Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301–1311PubMedCrossRef Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301–1311PubMedCrossRef
7.
go back to reference Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324PubMedCrossRef Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324PubMedCrossRef
8.
go back to reference Dalbeth N (2013) Management of gout in primary care: challenges and potential solutions. Rheumatology (Oxford) 52:1549–1550CrossRef Dalbeth N (2013) Management of gout in primary care: challenges and potential solutions. Rheumatology (Oxford) 52:1549–1550CrossRef
Metadata
Title
Gout: from international guidelines to current practice. Results from a physician questionnaire
Authors
Tristan Pascart
René-Marc Flipo
Publication date
01-11-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2402-4

Other articles of this Issue 11/2013

Clinical Rheumatology 11/2013 Go to the issue